SS
S. SRINIVASA RAO Dirigeant
Other
IN IN · SEBI (PIT + SAST)
Discover the complete record of transactions filed by S. SRINIVASA RAO, Dirigeant. Director active across 1 companies, notably Gland Pharma Limited. Cumulatively, 22 filings have been recorded. The latest transaction was disclosed on 26 February 2025 — Purchase. Regulator: SEBI (PIT + SAST). The full history is openly available.
Declarations 22 total
€16,540 2,800 shares @ €5.9073
Equity Shares
SEBI:7219b733f3d9d15f3f9020dbc6a9bb12c9ff8b1e · 26 Feb 2025
Ideal exit: 23 Nov 2025 (T+270) €39,506 1,950 shares @ €20.2595
Equity Shares
SEBI:f0701641538c4b901e0b3a0d1fe4eb2e3ab8f5aa · 27 Jun 2024
€20,379 1,000 shares @ €20.3791
Equity Shares
SEBI:225d8f1f09305affbbab911ef21fc9afb4ad2b81 · 25 Jun 2024
€20,351 1,000 shares @ €20.3506
Equity Shares
SEBI:8b69af0f66e683207b9cbbeea8ecb5fd725d2aac · 24 Jun 2024
€80,142 4,000 shares @ €20.0354
Equity Shares
SEBI:fc4ffe6e94442749792b8cdb7cb9e050d5a8cfec · 14 Dec 2023
€48,800 1,500 shares @ €32.5332
Equity Shares
SEBI:452a3ddd22326b35d5092fdff51d6295a1901e35 · 30 Jun 2022
€32,076 1,000 shares @ €32.076
Equity Shares
SEBI:3459a3e70f99220c7398f98c3bfc3935db2d5709 · 28 Jun 2022
€16,083 500 shares @ €32.1653
Equity Shares
SEBI:116e0488eaf3ff78bc477558447e8dd3903d02ae · 27 Jun 2022
€32,472 1,000 shares @ €32.4718
Equity Shares
SEBI:749dd500e45e5714941ec85424b2198640d872aa · 21 Jun 2022
€23,187 3,500 shares @ €6.6249
Equity Shares
SEBI:a3ed60cd9d9d8ee54f3a3838e12aac013b8567a2 · 15 Jun 2022
Ideal exit: 12 Mar 2023 (T+270) €46,486 1,000 shares @ €46.4856
Equity Shares
SEBI:a87a5e7588dbd1369a97713f9c3a7652eb19ba1a · 30 Dec 2021
€23,157 500 shares @ €46.3148
Equity Shares
SEBI:6a5f5cd44e69f352912ce5b876d463dd6e611664 · 29 Dec 2021
€4,602 100 shares @ €46.0189
Equity Shares
SEBI:a9883260ad32d13bdfd7b49eb3a93079b74fe157 · 24 Dec 2021
€40,493 900 shares @ €44.9919
Equity Shares
SEBI:3b314990c30abac91fc247fd1af208cb845520f6 · 23 Dec 2021
€8,804 200 shares @ €44.0204
Equity Shares
SEBI:df69ae495b07dc6c11f77e3b2cef5c35e482b89d · 20 Dec 2021
€24,770 500 shares @ €49.54 0.0000% mcap 17.8% of flow
Equity Shares
SEBI:72f00f999fd5e5b9600e77ae3ff904af9ad3132d · 12 Aug 2021
€33,643 700 shares @ €48.0611 0.0000% mcap 24.2% of flow
Equity Shares
SEBI:aeccbaecc6610c36ba5999f1b869a775ac747f33 · 10 Aug 2021
€37,294 800 shares @ €46.6178 0.0000% mcap 26.9% of flow
Equity Shares
SEBI:5e180742f6022c3b2fa18a87ab372ae0f154568d · 5 Aug 2021
€32,177 700 shares @ €45.9669 0.0000% mcap 23.2% of flow
Equity Shares
SEBI:fe8e5f4168906d90189cc42cd8e2e4f92e5a8820 · 26 Jul 2021
€17,197 2,800 shares @ €6.1419 0.0000% mcap 100.0% of flow
Equity Shares
SEBI:0b8d023344a568a140c885b2bebcb9dd51806488 · 5 Jul 2021
Ideal exit: 1 Apr 2022 (T+270) €18,461 500 shares @ €36.9223 0.0000% mcap 100.0% of flow
Equity Shares
SEBI:c7d70a87f3ec82bf347a67464278c275849cd92a · 28 May 2021
€10,980 300 shares @ €36.6007 0.0000% mcap 7.9% of flow
Equity Shares
SEBI:a0556eaeeb72674c65219d967dae8102ae1c7c44 · 25 May 2021
About S. SRINIVASA RAO S. Srinivasa Rao is an executive at Gland Pharma Limited, a company specializing in the manufacturing of pharmaceutical products. He oversees production operations and contributes to the company's strategy. Gland Pharma is known for its commitment to quality and innovation in the pharmaceutical sector.